Clinical Research Progress of the Ratio of Inflammatory Index Monocytes to High-density Lipoprotein Cholesterol in Postmenopausal Women with Osteoporosis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Postmenopausal osteoporosis is a major disease causing fractures and disability in elderly women, and its onset is closely related to chronic low-grade inflammation. The ratio of monocytes to high-density lipoprotein cholesterol, as an emerging comprehensive inflammation indicator, simultaneously reflects the imbalance of pro-inflammatory cell activation and anti-inflammatory lipoprotein protective function, providing a new perspective for understanding the inflammatory mechanism of postmenopausal osteoporosis. This article reviews the biological basis of MHR, explores its potential mechanisms involved in bone metabolism disorders by mediating oxidative stress, osteoclast activation and other pathways, and systematically evaluates its clinical application value and prospects in postmenopausal women's osteoporosis risk prediction, severity assessment and treatment response monitoring. Existing evidence shows that MHR is expected to become a convenient and economical auxiliary biomarker, but its clinical application still requires more prospective studies to verify.
Fields of Study & Subjects
Bone health and osteoporosis research
Bone Metabolism and Diseases
Menopause: Health Impacts and Treatments
Publication details
- Journal / source
- International Journal of Biology and Life Sciences
- Volume
- 13
- Issue
- 3
- Pages
- 162–165
- Publication date
- 30 March 2026
- Language
- EN